Correction to: siRNA modification and delivery for drug development: (Trends in Molecular Medicine, 28:10 p:892-893, 2022).
-
Authors
-
-
Zhang, Mengjie1
-
Huang, Yuanyu2
-
1
School of Life Science, Beijing Institute of Technology, Beijing 100081, China; Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology, Beijing 100081, China; Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, Beijing 100081, China.
,
(China)
-
2
School of Life Science, Beijing Institute of Technology, Beijing 100081, China; Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology, Beijing 100081, China; Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, Beijing 100081, China; School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China; Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology, Beijing 100081, China; Rigerna Therapeutics, Suzhou, Jiangsu 215127, China. Electronic address: [email protected].
,
(China)
- Type
- Published Article
- Journal
-
Trends in molecular medicine
- Publication Date
-
Jun 01, 2024
- Volume
-
30
- Issue
-
6
- Pages
-
605–605
- Identifiers
-
DOI: 10.1016/j.molmed.2022.09.003
-
PMID: 36243546
- Source
-
Medline
- Language
-
English
- License
-
Unknown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/02/2024 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/36243546
